AYTU BIOPHARMA, INC Investing Cash Flow
AYTU BIOPHARMA, INC (AYTU) reported Investing Cash Flow of -$29.00 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-22.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-09-22
- AYTU BIOPHARMA, INC net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$12.00K.
- AYTU BIOPHARMA, INC net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was $0.00.
- AYTU BIOPHARMA, INC net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$17.00K, a 111.72% decline year-over-year.
- AYTU BIOPHARMA, INC net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- AYTU BIOPHARMA, INC net cash provided by (used in) investing activities for fiscal 2026 was -$29.00K.
- AYTU BIOPHARMA, INC net cash provided by (used in) investing activities for fiscal 2025 was -$2.56M.
- AYTU BIOPHARMA, INC net cash provided by (used in) investing activities for fiscal 2024 was -$329.00K.
- AYTU BIOPHARMA, INC net cash provided by (used in) investing activities for fiscal 2023 was -$117.00K.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 3 month as first filed | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 6 month as first filed | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 9 month as first filed | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 12 month as first filed | Net Cash Provided by (Used in) Investing Activities 81 month | Net Cash Provided by (Used in) Investing Activities 84 month | Net Cash Provided by (Used in) Investing Activities 87 month | Net Cash Provided by (Used in) Investing Activities 90 month | Net Cash Provided by (Used in) Investing Activities 93 month | Net Cash Provided by (Used in) Investing Activities 96 month | Net Cash Provided by (Used in) Investing Activities 99 month | Net Cash Provided by (Used in) Investing Activities 102 month | Net Cash Provided by (Used in) Investing Activities 105 month | Net Cash Provided by (Used in) Investing Activities 108 month | Net Cash Provided by (Used in) Investing Activities 111 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-22 | -$12.00K derived: sum of 2 quarters · filed 2026-09-22 | -$29.00K derived: sum of 3 quarters · filed 2026-09-22 | -$29.00K 10-K · filed 2026-09-22 | |||||||||||||||
| 2026-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13 | -$17.00K derived: sum of 2 quarters · filed 2026-05-13 | -$17.00K 10-Q · filed 2026-05-13 | -$3.03M derived: sum of 4 quarters · filed 2026-09-22 | |||||||||||||||
| 2025-12-31 | -$17.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-03 | -$17.00K 10-Q · filed 2026-02-03 | -$3.03M derived: sum of 3 quarters · filed 2026-09-22 | -$3.10M derived: sum of 4 quarters · filed 2026-09-22 | |||||||||||||||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-13 | -$3.02M derived: sum of 2 quarters · filed 2026-09-22 | -$3.09M derived: sum of 3 quarters · filed 2026-09-22 | -$2.94M derived: sum of 4 quarters · filed 2026-09-22 | |||||||||||||||
| 2025-06-30 | -$3.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-22 | -$3.09M derived: sum of 2 quarters · filed 2026-09-22 | -$2.94M derived: sum of 3 quarters · filed 2026-09-22 | -$2.56M 10-K · filed 2026-09-22 | |||||||||||||||
| 2025-03-31 | -$69.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13 | $76.00K derived: sum of 2 quarters · filed 2026-05-13 | $457.00K 10-Q · filed 2026-05-13 | $423.00K derived: sum of 4 quarters · filed 2026-05-13 | |||||||||||||||
| 2024-12-31 | $145.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-03 | $526.00K 10-Q · filed 2026-02-03 | $492.00K derived: sum of 3 quarters · filed 2026-02-03 | $447.00K derived: sum of 4 quarters · filed 2026-02-03 | |||||||||||||||
| 2024-09-30 | $381.00K 10-Q · filed 2025-11-13 | $347.00K derived: sum of 2 quarters · filed 2025-11-13 | $381.00K 10-Q · filed 2024-11-13 | $128.00K derived: sum of 4 quarters · filed 2025-11-13 | |||||||||||||||
| 2024-06-30 | -$34.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | -$79.00K derived: sum of 2 quarters · filed 2025-09-23 | -$253.00K derived: sum of 3 quarters · filed 2025-09-23 | -$329.00K 10-K · filed 2025-09-23 | |||||||||||||||
| 2024-03-31 | -$45.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-14 | -$219.00K derived: sum of 2 quarters · filed 2025-05-14 | -$295.00K 10-Q · filed 2025-05-14 | -$450.00K derived: sum of 4 quarters · filed 2025-05-14 | |||||||||||||||
| 2023-12-31 | -$174.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-12 | -$250.00K 10-Q · filed 2025-02-12 | -$405.00K derived: sum of 3 quarters · filed 2025-02-12 | -$404.00K derived: sum of 4 quarters · filed 2025-02-12 | |||||||||||||||
| 2023-09-30 | -$76.00K 10-Q · filed 2023-11-14 | -$231.00K derived: sum of 2 quarters · filed 2024-09-26 | -$76.00K 10-Q · filed 2024-11-13 | -$235.00K derived: sum of 4 quarters · filed 2024-09-26 | |||||||||||||||
| 2023-06-30 | -$155.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-26 | -$154.00K derived: sum of 2 quarters · filed 2024-09-26 | -$159.00K derived: sum of 3 quarters · filed 2024-09-26 | -$117.00K 10-K · filed 2024-09-26 | |||||||||||||||
| 2023-03-31 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-15 | -$4.00K derived: sum of 2 quarters · filed 2024-05-15 | $38.00K 10-Q · filed 2024-05-15 | -$3.00K derived: sum of 4 quarters · filed 2024-05-15 | |||||||||||||||
| 2022-12-31 | -$5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-14 | $37.00K 10-Q · filed 2024-02-14 | -$4.00K derived: sum of 3 quarters · filed 2024-02-14 | -$74.00K derived: sum of 4 quarters · filed 2024-02-14 | |||||||||||||||
| 2022-09-30 | $42.00K 10-Q · filed 2023-11-14 | $1.00K derived: sum of 2 quarters · filed 2023-11-14 | -$69.00K derived: sum of 3 quarters · filed 2023-11-14 | -$3.12M derived: sum of 4 quarters · filed 2023-11-14 | |||||||||||||||
| 2022-06-30 | -$41.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-12 | -$111.00K derived: sum of 2 quarters · filed 2023-10-12 | -$3.16M derived: sum of 3 quarters · filed 2023-10-12 | -$3.25M 10-K · filed 2023-10-12 | |||||||||||||||
| 2022-03-31 | -$70.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-11 | -$3.12M derived: sum of 2 quarters · filed 2023-05-11 | -$3.21M 10-Q · filed 2023-05-11 | -$5.63M derived: sum of 4 quarters · filed 2023-05-11 | |||||||||||||||
| 2021-12-31 | -$3.05M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2023-02-21 | -$3.14M 10-Q · filed 2023-02-21 | -$5.56M derived: sum of 3 quarters · filed 2023-02-21 | -$5.88M derived: sum of 4 quarters · filed 2023-02-21 | |||||||||||||||
| 2021-09-30 | -$86.00K 10-Q/A · filed 2023-02-21 | -$2.51M derived: sum of 2 quarters · filed 2023-02-21 | -$2.83M derived: sum of 3 quarters · filed 2023-02-21 | -$2.86M derived: sum of 4 quarters · filed 2023-02-21 | |||||||||||||||
| 2021-06-30 | -$2.43M derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-27 | -$2.74M derived: sum of 2 quarters · filed 2022-09-27 | -$2.77M derived: sum of 3 quarters · filed 2022-09-27 | -$2.78M 10-K · filed 2022-09-27 | |||||||||||||||
| 2021-03-31 | -$317.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-16 | -$347.00K derived: sum of 2 quarters · filed 2022-05-16 | -$356.00K 10-Q · filed 2022-05-16 | -$364.09K 10-Q · filed 2021-05-17 | -$401.27K derived: sum of 4 quarters · filed 2022-05-16 | ||||||||||||||
| 2020-12-31 | -$30.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-14 | -$39.00K 10-Q · filed 2022-02-14 | -$46.68K 10-Q · filed 2021-02-11 | -$84.27K derived: sum of 3 quarters · filed 2022-02-14 | $259.63K derived: sum of 4 quarters · filed 2022-02-14 | ||||||||||||||
| 2020-09-30 | -$9.00K 10-Q · filed 2021-11-15 | -$16.94K 10-Q · filed 2020-11-12 | -$54.27K derived: sum of 2 quarters · filed 2021-11-15 | $289.63K derived: sum of 3 quarters · filed 2021-11-15 | -$4.62M derived: sum of 4 quarters · filed 2021-11-15 | ||||||||||||||
| 2020-06-30 | -$45.27K derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-28 | $298.63K derived: sum of 2 quarters · filed 2021-09-28 | -$4.61M derived: sum of 3 quarters · filed 2021-09-28 | -$5.66M 10-K · filed 2021-09-28 | -$5.66M 10-K · filed 2020-10-06 | ||||||||||||||
| 2020-03-31 | $343.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-17 | -$4.57M derived: sum of 2 quarters · filed 2021-05-17 | -$5.61M 10-Q · filed 2021-05-17 | -$5.71M derived: sum of 4 quarters · filed 2021-05-17 | |||||||||||||||
| 2019-12-31 | -$4.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-11 | -$5.95M 10-Q · filed 2021-02-11 | -$6.05M derived: sum of 3 quarters · filed 2021-02-11 | -$6.16M derived: sum of 4 quarters · filed 2021-02-11 | |||||||||||||||
| 2019-09-30 | -$1.04M 10-Q · filed 2020-11-12 | -$1.14M derived: sum of 2 quarters · filed 2020-11-12 | -$1.24M derived: sum of 3 quarters · filed 2020-11-12 | -$1.80M derived: sum of 4 quarters · filed 2020-11-12 | |||||||||||||||
| 2019-06-30 | -$96.11K derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-06 | -$201.70K derived: sum of 2 quarters · filed 2020-10-06 | -$758.81K derived: sum of 3 quarters · filed 2020-10-06 | -$1.06M 10-K · filed 2020-10-06 | |||||||||||||||
| 2019-03-31 | -$105.59K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-15 | -$662.70K derived: sum of 2 quarters · filed 2020-05-15 | -$965.88K 10-Q · filed 2020-05-15 | -$1.37M derived: sum of 4 quarters · filed 2020-05-15 | |||||||||||||||
| 2018-12-31 | -$557.11K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-14 | -$860.29K 10-Q · filed 2020-02-14 | -$1.26M derived: sum of 3 quarters · filed 2020-02-14 | -$1.33M derived: sum of 4 quarters · filed 2020-02-14 | |||||||||||||||
| 2018-09-30 | -$303.18K 10-Q · filed 2019-11-14 | -$705.38K derived: sum of 2 quarters · filed 2019-11-14 | -$775.27K derived: sum of 3 quarters · filed 2019-11-14 | ||||||||||||||||
| 2018-06-30 | -$402.20K derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-26 | -$472.10K derived: sum of 2 quarters · filed 2019-09-26 | -$484.29K 10-K · filed 2019-09-26 | ||||||||||||||||
| 2018-03-31 | -$69.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-14 | -$82.09K 10-Q · filed 2019-05-14 | |||||||||||||||||
| 2017-12-31 | -$12.20K 10-Q · filed 2019-05-14 | ||||||||||||||||||
| 2017-06-30 | -$3.53M 10-K · filed 2018-09-06 | ||||||||||||||||||
| 2014-05-31 | $0.00 derived: 10-Q 111 month − 10-Q 108 month · filed 2014-07-10 | $0.00 derived: sum of 2 quarters · filed 2014-07-10 | $0.00 derived: sum of 3 quarters · filed 2014-07-10 | $0.00 derived: sum of 4 quarters · filed 2014-11-26 | -$26.87K 10-Q · filed 2014-07-10 | ||||||||||||||
| 2014-02-28 | $0.00 derived: 10-Q 108 month − 10-Q 105 month · filed 2014-04-11 | $0.00 derived: sum of 2 quarters · filed 2014-04-11 | $0.00 derived: sum of 3 quarters · filed 2014-11-26 | $0.00 derived: sum of 4 quarters · filed 2014-11-26 | -$26.87K 10-Q · filed 2014-04-11 | ||||||||||||||
| 2013-11-30 | $0.00 derived: 10-Q 105 month − 10-K 102 month · filed 2014-01-10 | $0.00 derived: sum of 2 quarters · filed 2014-11-26 | $0.00 derived: sum of 3 quarters · filed 2014-11-26 | $0.00 derived: sum of 4 quarters · filed 2014-11-26 | -$26.87K 10-Q · filed 2014-01-10 | ||||||||||||||
| 2013-08-31 | $0.00 derived: 10-K 102 month − 10-Q 99 month · filed 2014-11-26 | $0.00 derived: sum of 2 quarters · filed 2014-11-26 | $0.00 derived: sum of 3 quarters · filed 2014-11-26 | $0.00 derived: sum of 4 quarters · filed 2014-11-26 | -$26.87K 10-K · filed 2014-11-26 | ||||||||||||||
| 2013-05-31 | $0.00 derived: 10-Q 99 month − 10-Q 96 month · filed 2013-06-28 | $0.00 derived: sum of 2 quarters · filed 2013-06-28 | $0.00 derived: sum of 3 quarters · filed 2013-06-28 | $0.00 derived: sum of 4 quarters · filed 2013-06-28 | -$26.87K 10-Q · filed 2013-06-28 | ||||||||||||||
| 2013-02-28 | $0.00 derived: 10-Q 96 month − 10-Q 93 month · filed 2013-04-15 | $0.00 derived: sum of 2 quarters · filed 2013-04-15 | $0.00 derived: sum of 3 quarters · filed 2013-04-15 | $0.00 derived: sum of 4 quarters · filed 2013-04-15 | -$26.87K 10-Q · filed 2013-04-15 | ||||||||||||||
| 2012-11-30 | $0.00 derived: 10-Q 93 month − 10-K 90 month · filed 2013-01-14 | $0.00 derived: sum of 2 quarters · filed 2013-01-14 | $0.00 derived: sum of 3 quarters · filed 2013-01-14 | $0.00 derived: sum of 4 quarters · filed 2013-01-14 | -$26.87K 10-Q · filed 2013-01-14 | ||||||||||||||
| 2012-08-31 | $0.00 derived: 10-K 90 month − 10-Q 87 month · filed 2012-11-29 | $0.00 derived: sum of 2 quarters · filed 2012-11-29 | $0.00 derived: sum of 3 quarters · filed 2012-11-29 | $0.00 derived: sum of 4 quarters · filed 2012-11-29 | -$26.87K 10-K · filed 2012-11-29 | ||||||||||||||
| 2012-05-31 | $0.00 derived: 10-Q 87 month − 10-Q 84 month · filed 2012-06-26 | $0.00 derived: sum of 2 quarters · filed 2012-06-26 | $0.00 derived: sum of 3 quarters · filed 2012-06-26 | -$26.87K 10-Q · filed 2012-06-26 | |||||||||||||||
| 2012-02-29 | $0.00 derived: 10-Q 84 month − 10-Q 81 month · filed 2012-04-12 | $0.00 derived: sum of 2 quarters · filed 2012-04-12 | -$26.87K 10-Q · filed 2012-04-12 | ||||||||||||||||
| 2011-11-30 | $0.00 10-Q · filed 2011-12-23 | -$26.87K 10-Q · filed 2011-12-23 | |||||||||||||||||
| 2010-11-30 | $0.00 10-Q · filed 2011-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |